Management and outcome of EGFR mutant lung cancer with SARS-CoV-2 infection
Description
The world and India, in particular, have been grappling with the coronavirus disease (COVID-19) pandemic for more than a year now. The simultaneous presence of active COVID-19 infection with lung cancer poses both a diagnostic and therapeutic dilemma
